SGYP

Synergy Pharmaceuticals to Give Plenary Presentation at the 16th Annual TIDES Summit

[Business Wire] – Synergy Pharmaceuticals Inc. , today announced its Chief Scientific Officer, Kunwar Shailubhai, PhD, MBA, will give a plenary presentation at the 16th Annual TIDES Sum moreView todays social media effects on SGYPView the latest stocks trending across Twitter. Click to view dashboardSee who Synergy is hiring next, click here to view […]

Synergy Pharmaceuticals Reports 2013 Fourth Quarter and Full-Year Financial Results

[Business Wire] – Synergy Pharmaceuticals Inc. , a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its financial results and business update for the fourth quarter and the year ended December 31, 2013. moreView todays social media effects on SGYPView the latest stocks trending across Twitter. Click to view dashboardSee who Synergy is hiring next, click […]

Synergy Pharmaceuticals’ Chief Scientific Officer to Present Plenary Lecture at the 2014 Southern Regional Meetings

[Business Wire] – Synergy Pharmaceuticals Inc. today announced its Chief Scientific Officer, Kunwar Shailubhai, Ph.D., M.B.A., will present a plenary lecture entitled, “Cyclic GMP: Und moreView todays social media effects on SGYPView the latest stocks trending across Twitter. Click to view dashboardSee who Synergy is hiring next, click here to view […]

Synergy Pharmaceuticals Announces Closing of Public Offering of Shares of Common Stock

[at noodls] – NEW YORK, April 16, 2013 — Synergy Pharmaceuticals Inc.(Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the closing of its underwritten public offering … moreView todays social media effects on SGYPView the latest stocks trending across Twitter. Click to view dashboardSee who Synergy is hiring next, click here to view […]